Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Liabilities: 2023-2024

Historic Total Liabilities for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $19.3 million.

  • Zhengye Biotechnology Holding's Total Liabilities was N/A to $19.3 million in Q2 2025 from the same period last year, while for Dec 2024 it was $19.3 million, marking a year-over-year decrease of 13.59%. This contributed to the annual value of $19.3 million for FY2024, which is 15.19% down from last year.
  • Zhengye Biotechnology Holding's Total Liabilities amounted to $19.3 million in FY2024, which was down 15.19% from $22.7 million recorded in FY2023.
  • Over the past 5 years, Zhengye Biotechnology Holding's Total Liabilities peaked at $22.7 million during FY2023, and registered a low of $19.3 million during FY2024.
  • In the last 2 years, Zhengye Biotechnology Holding's Total Liabilities had a median value of $21.0 million in 2023 and averaged $21.0 million.
  • Data for Zhengye Biotechnology Holding's Total Liabilities shows a maximum YoY dropped of 15.19% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Total Liabilities (Yearly) stood at $22.7 million in 2023, then decreased by 15.19% to $19.3 million in 2024.